申萬宏源(000166.SZ):申萬宏源證券獲得場外期權一級交易商資質無異議函
格隆匯 1 月 4日丨申萬宏源(000166.SZ)公佈,近日,公司所屬申萬宏源證券有限公司(“申萬宏源證券”)收到中國證監會《關於申萬宏源申請場外期權一級交易商資質的無異議函》(機構部函〔2020〕3529號),中國證監會對申萬宏源證券申請場外期權一級交易商資格無異議。
申萬宏源證券將嚴格按照《證券公司場外期權業務管理辦法》有關要求,以服務實體經濟為目標,以客户風險管理需求為導向,做好客户適當性管理,認真履行交易商職責,合規、審慎開展場外期權業務,並確保報送數據的真實、準確、完整、及時。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.